키토산은 키틴의 탈아세틸화반응을 통해서 얻어진 유전적 독성이 없는 천연착화제로써 방사성동위원소 혹은 중금속 이온의 제거제 및 체내 흡수 억제제로 알려져 왔다. 본 연구에서는 분자량이 다른 C-14 chitosan을 정맥투여 한 후 C-14 chitosan 분자량별 마우스 체내 대사과정을 알아보고자 하였다 ICR계 웅성 마우스(8-10주령, 체중 30-35g)를 사용하였다. C-14 chitosan은 증류수로 희석한 다음, 꼬리정맥을 통해 정맥 투여하였다. C-14 chitosan 투여후 6시간, 1일, 3일, 5일, 7일째 마우스를 희생시켜 혈액, 간, 신장, 비장, 폐, 근육, 고환, 오줌을 채취하였으며, 각각의 ${eta}$-방사능을 측정하여 상대농도를 구하였다. 대부분의 C-14 chitosan이 6시간째에 오줌을 통해 체외 배출되었고, 체내대사과정은 분자량이 서로 다름에도 불구하고 비슷하였다. 간, 신장, 비장등에서 높은 방사능을 나타내었다. 조직간의 상대농도는 6시간째에 증가하다가 서서히 감소함을 알 수 있었다. 결론적으로 정맥 투여한 키토산은 분자량에 상관없이 대부분 오줌을 통해 체외배출 되고, 체내 장기중의 대사과정은 비슷하게 나타났다.
Chitosan is a nontoxic natural chealtor which was made by chitin, and reduced a contamination of radiostrontium in animals. In this experiment, A different molecular weight of C-14 chitosan was intravenously administered to mice, and then the distribution of C-14 chitosan in the body was observed. Male mice (8 to 10 weeks, body weight of 30 to 35g) of ICR strain were used. C-14 chitosan was diluted with saline and then given intravenously in mice. After the administration of C-14 chitosan, mice was sacrificed at the 6th hour, 1st, 3rd, 5th, and 7th day. Beta radioactivities in the blood, liver, kidney, liver, muscle, testis, and urine was measured using a liquid scintillation analyzer. Most of the C-14 chitosan was excreted through urine within 6 hours. Biodistribution of C-14 chitosan was similar despite the difference of moleclar weight. Higher distributions of radioactivities were found in the liver, kidney, spleen. The relative concentration in tissue increased for the 6 hours and then decreased. In conclusion, most of C-14 chitosan was excreted through urine despite the difference of molecular weight. and, low molecular weight of C-14 chitosan showed higher distribution than high molecular weight of C-14 chitosan in tissues.
